ASX:IMR (USA)
Â
Chess Depository Interest
A$
1.865
+0.080 (+4.48%)
Jun 26
Business Description
Imricor Medical Systems Inc
NAICS : 334510
SIC : 3845
ISIN : AU0000054942
Share Class Description:
ASX:IMR: Chess Depository InterestDescription
Imricor Medical Systems Inc is a medical device company that develops MRI-guided technology to address issues with traditional X-ray ablation procedures. Its principal business activities are designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The company's products include the Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter, and Vision-MR Dispersive Electrode. Geographically, the company generates maximum revenue from Europe.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.57 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 2.25 | |||||
Debt-to-EBITDA | -1.02 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.4 | |||||
Beneish M-Score | -3.33 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -50 | |||||
3-Year EBITDA Growth Rate | 9.5 | |||||
3-Year EPS without NRI Growth Rate | 11.3 | |||||
3-Year FCF Growth Rate | 16.8 | |||||
3-Year Book Growth Rate | -8.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 15.58 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 360.03 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.4 | |||||
9-Day RSI | 58.75 | |||||
14-Day RSI | 55.72 | |||||
3-1 Month Momentum % | -11.17 | |||||
6-1 Month Momentum % | 19.05 | |||||
12-1 Month Momentum % | 11.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.47 | |||||
Quick Ratio | 2.41 | |||||
Cash Ratio | 2.35 | |||||
Days Inventory | 203.39 | |||||
Days Sales Outstanding | 354.63 | |||||
Days Payable | 65.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -27.1 | |||||
Shareholder Yield % | -12.44 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -690.81 | |||||
Operating Margin % | -8049.1 | |||||
Net Margin % | -8634.75 | |||||
EBITDA Margin % | -8633.18 | |||||
FCF Margin % | -6650.67 | |||||
OCF Margin % | -6502.24 | |||||
ROE % | -280.79 | |||||
ROA % | -61.34 | |||||
ROIC % | -247.9 | |||||
3-Year ROIIC % | -56.44 | |||||
ROC (Joel Greenblatt) % | -906.83 | |||||
ROCE % | -74.32 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1865 | |||||
PB Ratio | 34.54 | |||||
Price-to-Tangible-Book | 37.3 | |||||
EV-to-EBIT | -16.56 | |||||
EV-to-Forward-EBIT | -20.13 | |||||
EV-to-EBITDA | -16.56 | |||||
EV-to-Forward-EBITDA | -20.71 | |||||
EV-to-Revenue | 1429.53 | |||||
EV-to-Forward-Revenue | 107.14 | |||||
EV-to-FCF | -21.49 | |||||
Price-to-GF-Value | 18.65 | |||||
| Price-to-Net-Current-Asset-Value | 46.63 | |||||
| Price-to-Net-Cash | 62.17 | |||||
Earnings Yield (Greenblatt) % | -6.04 | |||||
FCF Yield % | -4.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Imricor Medical Systems Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.446 | ||
| EPS (TTM) (A$) | -0.122 | ||
| Beta | 1.5298 | ||
| 3-Year Sharpe Ratio | 1.1 | ||
| 3-Year Sortino Ratio | 2.9 | ||
| Volatility % | 46.6 | ||
| 14-Day RSI | 55.72 | ||
| 14-Day ATR (A$) | 0.08624 | ||
| 20-Day SMA (A$) | 1.785 | ||
| 12-1 Month Momentum % | 11.11 | ||
| 52-Week Range (A$) | 1.145 - 2.25 | ||
| Shares Outstanding (Mil) | 353.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Imricor Medical Systems Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Imricor Medical Systems Inc Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Imricor Medical Systems Inc Frequently Asked Questions
What is Imricor Medical Systems Inc(ASX:IMR)'s stock price today?
The current price of ASX:IMR is A$1.87. The 52 week high of ASX:IMR is A$2.25 and 52 week low is A$1.15.
When is next earnings date of Imricor Medical Systems Inc(ASX:IMR)?
The next earnings date of Imricor Medical Systems Inc(ASX:IMR) is .
Does Imricor Medical Systems Inc(ASX:IMR) pay dividends? If so, how much?
Imricor Medical Systems Inc(ASX:IMR) does not pay dividend.
Press Release
Articles on Imricor Medical Systems Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers